607723-87-5

Upstream product

• 607723-69-3 2-{[6-(4-methoxyphenoxy)pyrimidin-4-yl]methylamino}ethanol 
• 459-57-4 4-fluorobenzaldehyde 
• 150-76-5 4-methoxy-phenol 
• 607723-54-6 4-chloro-6-(4-methoxyphenoxy)pyrimidine 

Downstream Products

• 607723-33-1 5-(4-{2-[6-(4-methoxyphenoxy)pyrimidin-4-yl]methylamino ethoxy}benzyl)thiazolidine-2,4-dione 

Relevant academic research and scientific papers

Process development and scale-up of PPAR α/γ Dual agonist lobeglitazone sulfate (CKD-501)

A scaleable synthetic route to the potent PPARα/γ dual agonistic agent, lobeglitazone (1), used for the treatment of type-2 diabetes was developed. The synthetic pathway comprises an effective five-step synthesis. This process involves a consecutive synth

Molecular design, synthesis, and hypoglycemic and hypolipidemic activities of novel pyrimidine derivatives having thiazolidinedione

We previously reported the synthesis and biological activity of novel substituted pyridines and purines having thiazolidinedione with hypoglycemic and hypolipidemic activities. We now report the synthesis and antidiabetic activity of novel substituted pyr